Primary Nursing Diagnosis

Fluid volume deficit related to blood loss OUTCOMES. Fluid balance; Hydration; Circulation status

INTERVENTIONS. Bleeding reduction; Blood product administration; Intravenous therapy; Shock management

U PLANNING AND IMPLEMENTATION Collaborative

The patient may be confronted with a prolonged evaluation and a variety of treatments before uterine bleeding resumes a more normal pattern or stops completely. Activities are not restricted and can be continued as the woman tolerates them. If infection or anemia is identified, appropriate pharmacologic therapy is initiated. Hormonal manipulation may be indicated, requiring careful dosing and attention to compliance with the treatment plan. Surgical management typically begins with dilation and curettage to remove excessive endometrial buildup, but may include intrauterine cryosurgery, laser ablation of the endometrium, or as a last resort, a hysterectomy.

Pharmacologic Highlights

Medication or Drug Class

Dosage

Description

Rationale

Medroxyprogesterone

10 mg PO daily, for

Synthetic progestin

Will transform proliferative

acetate (Provera)

10 days (days 16-25

0 0

Post a comment